key: cord-0801446-ez1iby7y
authors: Leaf, David E.; Hayek, Salim S.
title: Questioning the Futility of Cardiopulmonary Resuscitation in Patients With Severe Coronavirus Disease 2019
date: 2021-03-26
journal: Crit Care Med
DOI: 10.1097/ccm.0000000000004999
sha: d8d8824b2a66354dad39de010c2793194b2dedc1
doc_id: 801446
cord_uid: ez1iby7y

nan

To the Editor: W e read with great interest the article published in a recent issue of Critical Care Medicine by Shah et al (1) . The authors conducted a single-center retrospective cohort study of hospitalized patients with coronavirus disease 2019 (COVID-19) to examine outcomes after inhospital cardiac arrest (IHCA) with attempted cardiopulmonary resuscitation (CPR). Among 1,094 hospitalized patients, 63 suffered from IHCA, with an in-hospital mortality of 100%. Similar findings were reported in two other recently reported single-center studies: one that included 31 patients with IHCA (2), and another that included 60 such patients (3), with a 100% inhospital mortality reported in both studies. The authors conclude that their study "raises important questions about the futility of ACLS measures in these patients. "

We recently reported the outcomes following IHCA using data from the Study of the Treatment and Outcomes in Critically Ill Patients with COVID-19, a large multicenter cohort study of critically ill adult patients with COVID-19 admitted to ICUs at 68 geographically diverse hospitals across the United States (4). Among 5,019 patients, 701 (14.0%) had IHCA, 400 of whom received CPR. A total of 48 of the 400 (12.0%) who received CPR survived to hospital discharge. These findings are consistent with those recently reported in a study of critically ill patients with non-COVID-19 disease from the American Heart Association Get With the Guidelines-Resuscitation registry (5). Our study (1) does not support the notion that CPR is universally futile in hospitalized patients with COVID-19, although we agree that outcomes are often poor and that early initiation of goals of care discussions in such patients is appropriate. Thus, we urge providers, patients, and families to exercise caution in using findings from single-center studies to inform life-and-death decisions regarding the potential futility of CPR.

Cardiopulmonary Resuscitation in Coronavirus Disease 2019 Patients REFERENCES

Is Cardiopulmonary Resuscitation Futile in Coronavirus Disease

The authors have disclosed that they do not have any potential conflicts of interest.

A t the time of submission of our recently published article (1) in Critical Care Medicine, there were no data regarding survival after in-hospital cardiac arrest among coronavirus disease 2019 (COVID-19) patients in the United States. We acknowledge that our study (1) raised concerns regarding the benefit of cardiopulmonary resuscitation (CPR) in hospitalized COVID-19 patients suffering cardiac arrest. However, the goal of our study (1) was to initiate robust debate and encourages further research into a very important question that has a significant impact on resource allocation. We did not suggest early termination of resuscitative efforts or premature withdrawal of life-sustaining measures for such patients.We agree with the authors that based on recent larger studies, CPR is not universally futile in hospitalized COVID-19 patients. However, our study (1) was unique in terms of patient demographics. More than 90% of patients in our study (1) were African-Americans. It is well known that African-Americans have significantly lower survival rates after cardiac arrest compared with Caucasian patients (2). Furthermore, our hospitalized COVID-19 patients were sicker with higher comorbidity burden compared with other areas (3).We would like to point out that we have mentioned the lack of generalizability of our findings in the Limitations section of our article (1) due to our unique patient population as well as the fact that it was a single-center study. We completely agree with the authors (4) that providers, patients, and families should exercise caution in using findings from single-center studies such as ours (1) to make decisions regarding resuscitative measures. We believe that goals of care conversations should be a core component of the care pathway for every critically ill patient at every stage of their care in the hospital. We hope our study (1) will encourage future research to explore racial differences in the outcomes of cardiac arrest in COVID-19 patients.